| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/03/2003 | US20030124537 Procaryotic libraries and uses |
| 07/03/2003 | US20030124534 Measuring expression of nucleotide sequences in cells |
| 07/03/2003 | US20030124531 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/03/2003 | US20030124530 Sequence-directed DNA-binding molecules compositons and methods |
| 07/03/2003 | US20030124529 Pregnancy-associated plasma protein-A2 (PAPP-A2) |
| 07/03/2003 | US20030124523 Organic compounds |
| 07/03/2003 | US20030124522 Method for the identification and/or the quantification of a target compound obtained from a biological sample upon chips |
| 07/03/2003 | US20030124520 Methods for identifying agents that cause a lethal phenotype, and agents thereof |
| 07/03/2003 | US20030124517 Hepatitis A virus nucleotide sequences, recombinant proteins and uses thereof |
| 07/03/2003 | US20030124513 RNA interfering molecule which modulates gene expression; human immunodeficiency virus (HIV); configurations; cleavage |
| 07/03/2003 | US20030124512 Simultaneous quantification of nucleic acids in diseased cells |
| 07/03/2003 | US20030124511 Method of production of purified hepatitis a virus particles and vaccine preparation |
| 07/03/2003 | US20030124508 Method for testing the hormonal effect of substances |
| 07/03/2003 | US20030124506 Modular systems and methods for using sample processing devices |
| 07/03/2003 | US20030124505 Recombinase; polynucleotide which hybridizes to target nucleic acid; robotic system to manipulate pipettors, sample/plate handlers and other devices |
| 07/03/2003 | US20030124169 Biocompatible, biodegradable matrix and a protein, produced by expression of recombinant DNA capable of inducing endochondral bone formation in association with said matrix |
| 07/03/2003 | US20030124146 Recombinant Rhabdoviruses as live-viral vaccines |
| 07/03/2003 | US20030124145 Avian polynucleotide vaccine formula |
| 07/03/2003 | US20030124142 Immunomodulatory constructs and their uses |
| 07/03/2003 | US20030124137 For use in combatting a parasitic infestation of helminths; preferably of Fasciola or Dicrocoelium origin |
| 07/03/2003 | US20030124129 Angiopoietin-2 specific binding agents |
| 07/03/2003 | US20030124124 ES-2 polypeptide encoding nucleic acid cloned from Schistosoma mansoni and shown to bind and inhibit chemokine function, including CC chemokines such as MIP-1 alpha and/or RANTES |
| 07/03/2003 | US20030124123 Also an IL-12 anti-idiotype antibody to the antibody |
| 07/03/2003 | US20030124117 Combinations of anti-tissue factor antibodies and anticoagulant and/or antiplatelet agents |
| 07/03/2003 | US20030124116 Antibodies binding to polypeptides encoded by the genes |
| 07/03/2003 | US20030124115 A carboxy terminal peptide fragment of thrombopoietin is fused with the carboxy terminal of human erythropoietin; highly enhanced in vivo half-life due to increased carbohydrate content; no antigenicity |
| 07/03/2003 | US20030124114 Genes that encode cell surface molecules with conserved IgV and mucin domains; diagnosis or staging of cancer; treatment of an immunological disorder; detecting a predisposition to asthma |
| 07/03/2003 | US20030124113 Human apoptosis associated proteins |
| 07/03/2003 | US20030124108 Useful in wound healing, autoimmune disorders and inflammatory diseases |
| 07/03/2003 | US20030124107 PAK5-related compositions and methods |
| 07/03/2003 | US20030124106 Diagnosing, treating, or preventing disorders associated with expression of ORP. |
| 07/03/2003 | US20030124105 Programmed cell death genes and proteins |
| 07/03/2003 | US20030124100 Includes an endothelial specific enhancer element; especially modifications of the PPE promoter, which enhance its expression in response to hypoxia and angiogenesis. |
| 07/03/2003 | US20030124097 Method to improve the safety of gene therapy |
| 07/03/2003 | US20030124096 DNA virus, which replicates via an RNA intermediate,that comprises a nucleotide mutation in a gene encoding a DNA polymerase or part thereof; particularly hepatitis B variants |
| 07/03/2003 | US20030124094 Increasing or maintaining the blood supply in the penis |
| 07/03/2003 | US20030124092 IL-17 like molecules and uses thereoflike molecules and uses thereof |
| 07/03/2003 | US20030124090 Modulation of the polyvalent cation sensing receptor in the olfactory apparatus, and then exposing the fish with the same odorant after transfer to seawater or freshwater; attracting and repelling fish by modulating the expression of PVCR |
| 07/03/2003 | US20030124033 Method and apparatus for liposome production |
| 07/03/2003 | US20030124029 Microtitre well plate; efficient binding analysis |
| 07/03/2003 | US20030121854 Complexing ligand with compound; separation, purification; chromatography |
| 07/03/2003 | DE19964220C2 Modified nucleic acid oligomer, useful for sequencing by hybridization, is substituted by redox agent to allow electrical detection of hybridization |
| 07/03/2003 | CA2803931A1 Methods for producing hyaluronan in a recombinant host cell |
| 07/03/2003 | CA2510745A1 Human antibodies against human glycoprotein vi and their use |
| 07/03/2003 | CA2486930A1 Anti-tirc7 antibodies in therapy of inflammatory diseases |
| 07/03/2003 | CA2486689A1 Therapeutic monoclonal anti-tirc7 antibodies for use in immune related and other diseases |
| 07/03/2003 | CA2471465A1 Novel g-protein coupled receptors |
| 07/03/2003 | CA2471417A1 Uses of an endothelial cell receptor |
| 07/03/2003 | CA2471375A1 Chitin oligosaccharide elicitor-and gibberellin-responsive genes in plants, and uses thereof |
| 07/03/2003 | CA2471373A1 Modified tridegins, their preparation and their use as transglutaminase inhibitors |
| 07/03/2003 | CA2471369A1 Glycosyl hydrolases obtained from metagenomic analysis |
| 07/03/2003 | CA2471160A1 Seminal vesicle tissue-specific promoters and uses thereof |
| 07/03/2003 | CA2471140A1 Antibodies that immunospecifically bind to trail receptors |
| 07/03/2003 | CA2471116A1 Method for cloning of variable domain sequences |
| 07/03/2003 | CA2471110A1 Peptides for treatment of the human papillomavirus(hpv)-associated cancer and other epithelial tumors |
| 07/03/2003 | CA2470999A1 Syn3 compositions and methods |
| 07/03/2003 | CA2470943A1 Forming and modifying dielctrically-engineered microparticles |
| 07/03/2003 | CA2470844A1 Novel compositions and methods for cancer |
| 07/03/2003 | CA2470724A1 Devices and methods for isolating and detecting specific substances in complex matrices |
| 07/03/2003 | CA2470594A1 Leptin proteins |
| 07/03/2003 | CA2470329A1 Methods for the transformation of vegetal plastids |
| 07/03/2003 | CA2470178A1 Mammalian simp protein, gene sequence and uses thereof in cancer therapy |
| 07/03/2003 | CA2470163A1 Array plates and method for constructing array plates |
| 07/03/2003 | CA2470148A1 Inhibition of tristetraproline for protection of the heart from cardiac injuries |
| 07/03/2003 | CA2470063A1 Parmaceutical agents and methods for tissue and vascular regeneration |
| 07/03/2003 | CA2469999A1 Methods and devices for removal of organic molecules from biological mixtures using a hydrophilic solid support in a hydrophobic matrix |
| 07/03/2003 | CA2469980A1 Methods and devices for removal of organic molecules from biological mixtures using anion exchange |
| 07/03/2003 | CA2469928A1 Nucleic acid labeling by thermoanaerobacter thermohydrosulfuricus dna polymerase i variants |
| 07/03/2003 | CA2469658A1 Adeno-associated virus-mediated delivery of gdnf to skeletal muscles |
| 07/03/2003 | CA2469487A1 Mutated hiv tat |
| 07/03/2003 | CA2469375A1 Maize ccoaomt2 gene polymorphism, and uses thereof to enhance plant digestibility |
| 07/03/2003 | CA2469263A1 Raf/ras binding compounds |
| 07/03/2003 | CA2468972A1 Methods of treating psychosis and schizophrenia based on a polymorphism in the ctf gene |
| 07/03/2003 | CA2468882A1 A library of modified structural genes or capsid modified particles useful for the identification of viral clones with desired cell tropism |
| 07/03/2003 | CA2468854A1 Method and system for depleting rrna populations |
| 07/03/2003 | CA2468778A1 Isolation tool for viable c-kit expressing cells |
| 07/03/2003 | CA2468627A1 Liposome composition for delivery of nucleic acid |
| 07/03/2003 | CA2468083A1 Use of heterocyclic carboxamides to treat anemia |
| 07/03/2003 | CA2467207A1 Novel phytases and method for producing these phytases |
| 07/03/2003 | CA2467099A1 Method for the recovery and purification of poxviruses from infected cells |
| 07/03/2003 | CA2466885A1 Non-human primate fc receptors and methods of use |
| 07/03/2003 | CA2466483A1 Diagnosis prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling |
| 07/03/2003 | CA2465283A1 Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
| 07/03/2003 | CA2464885A1 A method of reducing non-specific amplification in pcr |
| 07/03/2003 | CA2462670A1 Sperm-specific cation channel, catsper2, and uses therefor |
| 07/03/2003 | CA2453810A1 Mutant proteinase inhibitors and uses thereof |
| 07/03/2003 | CA2451677A1 Compositions and methods utilizing dna polymerases |
| 07/02/2003 | EP1324357A1 Electromagnetic device and high-voltage generating device and method of producing electromagnetic device |
| 07/02/2003 | EP1323835A2 Method for determining biospecies contained in test specimen and kit used for the same |
| 07/02/2003 | EP1323834A2 Target detection method, reagent and method for detecting SNP of DNA nucleotide sequences |
| 07/02/2003 | EP1323833A1 Method of determining base sequence |
| 07/02/2003 | EP1323827A2 Method for producing optically active 2-hydroxycycloalkanecarboxylic acid ester |
| 07/02/2003 | EP1323826A1 A cell line expressing mutated human tissue - type plasminogen activator, the constructing strategy thereof and method of preparing expressed protein |
| 07/02/2003 | EP1323825A2 Recombinant plants and DNA constructs |
| 07/02/2003 | EP1323824A2 Use of human keratinocyte growth factor-2 for the preparation of pharmaceutical compositions |
| 07/02/2003 | EP1323823A2 Mammalian secretory peptide 9, antibodes against it and their use |
| 07/02/2003 | EP1323822A2 Transgenic Virus for use as pesticide |
| 07/02/2003 | EP1323820A2 Process for facillitated recovery of heterologous proteins from bacterial cells |
| 07/02/2003 | EP1323737A2 Il-3 variant hematopoiesis fusion protein |
| 07/02/2003 | EP1323736A1 Chimeric human-type vascular endothelial cell growth factor |